Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Study-OPTIMAL - Rituximab 375, DLBCL

Protocol-ID: 1132 V1.0 (Mini), STUDY-OPTIMAL - RITU375, DLBCL

Indication(s)

  • NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 14.06.2018